Re: from IR/Chris

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KayakerBC

Rank: Treasurer [?]

Points: 1691 [?]

Votes: 23 Score: 2.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: from IR/Chris

in response to

Re: from IR/Chris

Nextblockbuster

posted on Dec 15, 2022 02:25PM

Near future? Would be nice but I don't see that happening until we see good Phase II results. Hopefully a sale in the next couple of years. And $$$ in our pockets.

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply